Heartflow (HTFL) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.03
- Estimate
- -$0.10
- Surprise
- +70.7%
- Revenue (period 2026-09-30)
- $72.9M
- Score today
- 5.6/10
Revenue source: xbrl.
How the report landed
Heartflow (HTFL) reported a narrower loss than forecast — adjusted EPS of -$0.03 against the -$0.10 estimate (a 70.7% beat on a still-unprofitable quarter).
Coverage in the report window
- HeartFlow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance — fiscal.ai, 2026-11-12
- HeartFlow Q3 Adj. EPS $(0.03) Beats $(0.10) Estimate, Sales $72.857M Beat $65.264M Estimate — benzinga, 2026-11-12
- HeartFlow Raises FY2026 Sales Guidance from $246.000M-$250.000M to $262.000M-$264.000M vs $248.778M Est — benzinga, 2026-11-12
Where TrendMatrix's rating stands now
TrendMatrix currently rates HTFL Sell at 5.6/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +70.7% surprise compares with a +34.1% four-quarter average.
What supports the rating
- Strong earnings beat streak (3/4)
- Strong growth profile
What argues against it
- Concentration risk — Product: Heartflow FFRCT Analysis (98.0%)
- Analyst target reached - limited upside remaining
- Near 52-week high (1.2% away)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $59.92
- Stop
- $55.73
Risk check: trading volume is running 2.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-13 — shown for context, not personalized investment advice.
HTFL at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $5.21B
- P/E (fwd)
- -220.8
- 52-week range
- $20.13–$60.66
- Off 52-week high
- 1.2%
- RSI (14)
- 56
- Volume vs avg
- 2.45×
- Score today
- 5.6/10